blindede placebo- kontrollerede undersøgelser af Nespo, hvor i alt 2112 patienter deltog (Nespo 1200, placebo 912).
Adverse reactions were determined based on pooled data from seven randomised, double-blind, placebo-controlled studies of Nespo with a total of 2112 patients (Nespo 1200, placebo 912).